• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 0.69% Nasdaq Down 1.07%

    Esperion Therapeutics, Inc. (ESPR)

    -NasdaqGM
    47.95 Down 4.56(8.68%) Aug 31, 4:00PM EDT
    |After Hours : 48.06 Up 0.11 (0.23%) Aug 31, 7:30PM EDT
    Add to Portfolio
    Prev Close:52.51
    Open:51.65
    Bid:N/A
    Ask:48.00 x 400
    1y Target Est:120.60
    Beta:-0.157124
    Earnings Date:Nov 9 - Nov 13 (Est.)
    Day's Range:47.73 - 52.42
    52wk Range:15.00 - 120.96
    Volume:1,534,362
    Avg Vol (3m):1,342,570
    Market Cap:1.08B
    P/E (ttm):N/A
    EPS (ttm):-2.22
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    ESPRDown 8.68%1.08B
    PFEDown 1.35%198.71B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):N/A
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-2.40
    Quarterly EPS Est (Sep-15) :-0.60
    Mean Recommendation*:2.1
    PEG Ratio (5 yr expected):0.45

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Esperion Therapeutics, Inc., a biopharmaceutical company, focuses on the research, development, and commercialization of oral and low-density lipoprotein cholesterol lowering therapies for the treatment of patients with hypercholesterolemia and ot... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback